EUPRAXIA PHARMACEUTICALS

Eupraxia is a clinical-stage biotechnology company developing targeted therapies that leverage a proprietary extended-release delivery system to provide the right dose of a drug, in the right place, for the right amount of time... VICTORIA, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to optimize local, controlled drug delivery for

Also known as: Eupraxia, Eupraxia Pharma, Inc., Eupraxia Pharmaceuticals Australia PTY Ltd., Eupraxia Pharmaceuticals Inc., Eupraxia Pharmaceuticals USA, LLC

Primary location: Victoria Canada